688266 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Suzhou Zelgen Biopharmaceuticals Co., Ltd. engages in the innovation, research, development, manufacturing, and commercialization of new medications. Its products include tablets and capsules of small molecule drugs and protein drugs, which are mainly for the treatments of cancer and hematologic diseases. The company was founded by Ze Lin Sheng, Hui Ping Lu, and Su Liu on March 18, 2009 and is headquartered in Kunshan, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
688266 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company